Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP502951.RAEoyak4FUyyr1FtPW4g1fnLpFTsFC6CvJjr3lCv_ONf4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP502951.RAEoyak4FUyyr1FtPW4g1fnLpFTsFC6CvJjr3lCv_ONf4130_assertion type Assertion NP502951.RAEoyak4FUyyr1FtPW4g1fnLpFTsFC6CvJjr3lCv_ONf4130_head.
- NP502951.RAEoyak4FUyyr1FtPW4g1fnLpFTsFC6CvJjr3lCv_ONf4130_assertion description "[The naturally occurring human lipoprotein lipase S447X variant (LPLS447X) exemplifies a gain-of function mutation with significant benefits including decreased plasma triglycerides (TG), increased high-density lipoprotein (HDL) cholesterol, and reduced risk of coronary artery disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP502951.RAEoyak4FUyyr1FtPW4g1fnLpFTsFC6CvJjr3lCv_ONf4130_provenance.
- NP502951.RAEoyak4FUyyr1FtPW4g1fnLpFTsFC6CvJjr3lCv_ONf4130_assertion evidence source_evidence_literature NP502951.RAEoyak4FUyyr1FtPW4g1fnLpFTsFC6CvJjr3lCv_ONf4130_provenance.
- NP502951.RAEoyak4FUyyr1FtPW4g1fnLpFTsFC6CvJjr3lCv_ONf4130_assertion SIO_000772 16002740 NP502951.RAEoyak4FUyyr1FtPW4g1fnLpFTsFC6CvJjr3lCv_ONf4130_provenance.
- NP502951.RAEoyak4FUyyr1FtPW4g1fnLpFTsFC6CvJjr3lCv_ONf4130_assertion wasDerivedFrom befree-2016 NP502951.RAEoyak4FUyyr1FtPW4g1fnLpFTsFC6CvJjr3lCv_ONf4130_provenance.
- NP502951.RAEoyak4FUyyr1FtPW4g1fnLpFTsFC6CvJjr3lCv_ONf4130_assertion wasGeneratedBy ECO_0000203 NP502951.RAEoyak4FUyyr1FtPW4g1fnLpFTsFC6CvJjr3lCv_ONf4130_provenance.